advertisement
Belfort R 17
Showing records 1 to 17 | Display all abstracts from Belfort R81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Furtado JM
Ophthalmic Epidemiology 2019; 26: 345-354
81110 Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan and Arulatan) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
Brant Fernandes RA
Clinical Ophthalmology 2019; 13: 679-684
81116 Vogt-Koyanagi-Harada Syndrome in Brazilian Children
Marquezan MC
Ocular Immunology and Inflammation 2019; 0: 1-7
81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Berezovsky A
Ophthalmic Epidemiology 2019; 26: 345-354
81116 Vogt-Koyanagi-Harada Syndrome in Brazilian Children
Nascimento H
Ocular Immunology and Inflammation 2019; 0: 1-7
81110 Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan and Arulatan) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
Silva LMP; Dias DT
Clinical Ophthalmology 2019; 13: 679-684
81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Ferraz NN
Ophthalmic Epidemiology 2019; 26: 345-354
81116 Vogt-Koyanagi-Harada Syndrome in Brazilian Children
Dalbem D
Ocular Immunology and Inflammation 2019; 0: 1-7
81110 Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan and Arulatan) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
Pereira RH
Clinical Ophthalmology 2019; 13: 679-684
81116 Vogt-Koyanagi-Harada Syndrome in Brazilian Children
Muccioli C
Ocular Immunology and Inflammation 2019; 0: 1-7
81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Muñoz S
Ophthalmic Epidemiology 2019; 26: 345-354
81110 Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan and Arulatan) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
Belfort R
Clinical Ophthalmology 2019; 13: 679-684
81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Fernandes AG
Ophthalmic Epidemiology 2019; 26: 345-354
81116 Vogt-Koyanagi-Harada Syndrome in Brazilian Children
Belfort R
Ocular Immunology and Inflammation 2019; 0: 1-7
81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Watanabe SS
Ophthalmic Epidemiology 2019; 26: 345-354
81110 Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan and Arulatan) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
Prata TS
Clinical Ophthalmology 2019; 13: 679-684
81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cunha CC; Vasconcelos GC; Sacai PY; Cypel M; Mitsuhiro MH; Morales PH; Cohen MJ; Campos M; Cohen JM; Belfort R; Salomão SR
Ophthalmic Epidemiology 2019; 26: 345-354
